J&J Says Phase 4 TREMFYA Study Met Key Endpoints in Axial PsA
TREMFYA showed statistically significant improvement versus placebo in axial psoriatic arthritis, according to the supplied report.
TREMFYA showed statistically significant improvement versus placebo in axial psoriatic arthritis, according to the supplied report.